Advances in Nanotechnology and Microfluidics for Human Papillomavirus Diagnostics

Proceedings of the IEEE

Volumn 103, Issue 2, 2015, Pages 161-178

  Tasoglu, Savas ^a   Cumhur Tekin, H ^b   Inci, Fatih ^b   Knowlton, Stephanie ^b   Wang, Shu Qi ^a,c   Wang Johanning, Feng ^d   Johanning, Gary ^e   Colevas, Dimitrios ^f   Demirci, Utkan ^f  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b STANFORD UNIVERSITY   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e SRI INTERNATIONAL   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRIES; DISEASES; MICROFLUIDICS; NANOTECHNOLOGY; ONCOGENIC VIRUSES; PATIENT TREATMENT;

CERVICAL CANCERS; CLINICAL UTILITY; DIAGNOSTIC METHODS; EARLY DIAGNOSIS; HUMAN PAPILLOMAVIRUS; LOW SENSITIVITY; NEW APPROACHES; POSITIVE/NEGATIVE;

DIAGNOSIS;

EID: 84938907414     PISSN: 00189219     EISSN: 15582256     Source Type: Journal    
DOI: 10.1109/JPROC.2014.2384836     Document Type: Article

References (103)

1. Y.-L. Qiao et al., "A new HPV-DNA test for cervical-cancer screening in developing regions: A cross-sectional study of clinical accuracy in rural China, " The Lancet Oncol., vol. 9, pp. 929-936, 2008.
2. D. M. Parkin and F. Bray, "Chapter 2: The burden of HPV-related cancers, " Vaccine, vol. 24, Supplement 3, pp. S11-S25, 2006.
3. R. Sankaranarayanan et al., "HPV screening for cervical cancer in rural india, " New England J. Med., vol. 360, pp. 1385-1394, 2009.
4. S. Bedford, "Cervical cancer: Physiology, risk factors, vaccination and treatment, " Br J Nurs, vol. 18, pp. 80-84, 2009.
5. J. Cuzick et al., "New technologies and procedures for cervical cancer screening, " Vaccine, vol. 30, Supplement 9, pp. F107-F116, 2012.
6. J. Cuzick et al., "Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries, " Vaccine, vol. 26, Supplement 10, pp. K29-K41, 2008.
7. Accessed on, Aug. 8, 2014. [Online]. Available: http://www.thehpvtest.com/
8. M. Schiffman and P. E. Castle, "The promise of global cervical-cancer prevention, " New England J. Med., vol. 353, pp. 2101-2104, 2005.
9. K. M. Ostrowska et al., "Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy, " Analyst, vol. 135, pp. 3087-3093, 2010.
10. D. Saslow et al., "American Cancer Society, American Society for Colposcopy and Cervical Pathology, American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer, " CA Cancer J. Clin., vol. 62, pp. 147-172, May/Jun. 2012.
11. A. Arney and K. M. Bennett, "Molecular diagnostics of human papillomavirus, " Lab Medicine, vol. 41, pp. 523-530, Sep. 1, 2010, 2010.
12. D. Devegowda, P. Doddamani, and P. Vishwanath, "Human papillomavirus screening: Time to add molecular methods with cytology, " Int. J. Health Allied Sci., vol. 3, pp. 145-146, 2014.
13. K. Nanda et al., "Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalitiesa systematic review, " Ann. Intern. Med., vol. 132, pp. 810-819, 2000.
14. I. Magrath et al., "Paediatric cancer in low-income and middle-income countries, " Lancet Oncol., vol. 14, pp. e104-16, Mar. 2013.
15. J. M. Crow, "HPV: The global burden, " Nature, vol. 488, pp. S2-S3, 2012.
16. N. G. Clearinghouse, "Guideline synthesis: Screening for cervical cancer, " Mar. 2013, (Revised).
17. H. M. Shingleton, R. L. Patrick, W. W. Johnston, and R. A. Smith, "The current status of the Papanicolaou smear, " CA: Cancer J. Clin., vol. 45, pp. 305-320, 1995.
18. E.-M. De Villiers, C. Fauquet, T. R. Broker, H.-U. Bernard, and H. zur Hausen, "Classification of papillomaviruses, " Virology, vol. 324, pp. 17-27, 2004.
19. L.-W. Huang, S.-L. Chao, P.-H. Chen, and H.-P. Chou, "Multiple HPV genotypes in cervical carcinomas: Improved DNA detection and typing in archival tissues, " J. Clin. Virol., vol. 29, pp. 271-276, 2004.
20. S. J. Hwang and K. R. Shroyer, "Biomarkers of cervical dysplasia and carcinoma, " J. Oncol., vol. 2012, 2011.
21. J. Ferlay et al., Cancer Incidence and Mortality Worldwide. Lyon, France: IARC Cancer Base, 2013, No. 11.
22. L. Bruni et al., "Summary Report 2014-08-22, " in Human Papillomavirus and Related Diseases in the World, ICO Information Centre on HPB and Cancered.
23. C. P. Chan, L. C. Tzang, K. K. Sin, S. L. Ji, K. Y. Cheung, T. K. Tam et al., "Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid, " Anal. Chim. Acta, vol. 584, pp. 7-11, Feb. 12, 2007.
24. R. Ricco, A. Meneghello, and F. Enrichi, "Signal enhancement in DNA microarray using dye doped silica nanoparticles: Application to human papilloma virus (HPV) detection, " Biosens. Bioelectron., vol. 26, pp. 2761-2765, Jan. 15, 2011.
25. W. Wang, D.-W. Pang, and H.-W. Tang, "Sensitive multiplexed DNA detection using silica nanoparticles as the target capturing platform, " Talanta, vol. 128, pp. 263-267, Oct. 1, 2014.
26. D. S. Xiang, G. P. Zeng, and Z. K. He, "Magnetic microparticle-based multiplexed DNA detection with biobarcoded quantum dot probes, " Biosens. Bioelectron., vol. 26, pp. 4405-4410, Jul. 15, 2011.
27. W. Yu-Hong, C. Rui, and L. Ding, "A quantum dots and superparamagnetic nanoparticle-based method for the detection of HPV DNA, " Nanoscale Res. Lett., vol. 6, p. 461, 2011.
28. H. Zhang, L. Liu, C. W. Li, H. Fu, Y. Chen, and M. Yang, "Multienzyme-nanoparticles amplification for sensitive virus genotyping in microfluidic microbeads array using Au nanoparticle probes and quantum dots as labels, " Biosens. Bioelectron., vol. 29, pp. 89-96, Nov. 15, 2011.
29. T. Brandstetter et al., "A polymer-based DNA biochip platform for human papilloma virus genotyping, " J. Virol. Meth., vol. 163, pp. 40-48, Jan. 2010.
30. W. Yue et al., "Single layer linear array of microbeads for multiplexed analysis of DNA and proteins, " Biosens. Bioelectron., vol. 54, pp. 297-305, Apr. 15, 2014.
31. A. Severini and V. Goleski, Set of Probes for the Detection and Typing of 46 Human Papillomavirus Mucosal Types. Mountain View, CA, USA: Google, 2013.
32. J. W. Li, J. Y. Lee, and E. S. Yeung, "Quantitative screening of single copies of human papilloma viral DNA without amplification, " Analytical Chemistry, vol. 78, pp. 6490-6496, Sep. 15, 2006.
33. J. Y. Lee, J. Li, and E. S. Yeung, "Single-molecule detection of surface-hybridized human papilloma virus DNA for quantitative clinical screening, " Anal. Chem., vol. 79, pp. 8083-8089, Nov. 1, 2007.
34. Y. Xu et al., "Fluorescent probe-based lateral flow assay for multiplex nucleic Acid detection, " Anal. Chem., vol. 86, pp. 5611-5614, Jun. 17, 2014.
35. S. J. Kim, K. B. Nahm, J. B. Lim, S. W. Oh, and E. Y. Choi, "A rapid and sensitive detection of HPV by combined assay of PCR and fluorescence DNA chip, " Biochip J., vol. 8, pp. 48-54, Mar. 20, 2014.
36. D. Summerer et al., "A flexible and fully integrated system for amplification, detection and genotyping of genomic DNA targets based on microfluidic oligonucleotide arrays, " New Biotechnol., vol. 27, pp. 149-155, May 31, 2010.
37. J. Felbel et al., "Reverse transcription-polymerase chain reaction (RT-PCR) in flow-Through micro-reactors: Thermal and fluidic concepts, " Chem. Eng. J., vol. 135, pp. S298-S302, Jan. 15, 2008.
38. J. Felbel et al., "Technical concept of a flow-Through microreactor for in-situ RT-PCR, " Eng. Life Sci., vol. 8, pp. 68-72, 2008.
39. C. Zhang and D. Xing, "Single-molecule DNA amplification and analysis using microfluidics, " Chem. Rev., vol. 110, pp. 4910-4947, 2010, 2010/08/11.
40. J. Compton, "Nucleic acid sequence-based amplification, " Nature, vol. 350, pp. 91-92, 1991.
41. A. Gulliksen et al., "Real-Time nucleic acid sequence-based amplification in nanoliter volumes, " Anal. Chem., vol. 76, pp. 9-14, 2003, 2004/01/01.
42. P. J. Asiello and A. J. Baeumner, "Miniaturized isothermal nucleic acid amplification, a review, " Lab on a Chip, vol. 11, pp. 1420-1430, 2011.
43. A. Gulliksen et al., "Towards a 'sample-in, answer-out' point-of-care platform for nucleic acid extraction and amplification: Using an HPV E6/E7 mRNA model system, " J. Oncol., vol. 2012, p. 905024, 2012.
44. A. Gulliksen et al., "Parallel nanoliter detection of cancer markers using polymer microchips, " Lab on a Chip, vol. 5, pp. 416-420, 2005.
45. L. Furuberg et al., "RNA amplification chip with parallel microchannels and droplet positioning using capillary valves, " Microsyst. Technol., vol. 14, pp. 673-681, 2008, 2008/04/01.
46. T. Baier et al., "Hands-free sample preparation platform for nucleic acid analysis, " Lab on a Chip, vol. 9, pp. 3399-3405, 2009.
47. B. R. Schudel, M. Tanyeri, A. Mukherjee, C. M. Schroeder, and P. J. A. Kenis, "Multiplexed detection of nucleic acids in a combinatorial screening chip, " Lab on a Chip, vol. 11, pp. 1916-1923, 2011.
48. F. Inci et al., "Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood, " ACS Nano, vol. 7, pp. 4733-4745, 2013.
49. H. Shafiee et al., "Nanostructured optical photonic crystal biosensor for HIV viral load measurement, " Sci. Rep., vol. 4, 2014.
50. O. Tokel, F. Inci, and U. Demirci, "Advances in plasmonic technologies for point of care applications, " Chemical reviews, 2014.
51. X. Z. Li, S. Kim, W. Cho, and S. Y. Lee, "Optical detection of nanoparticle-enhanced human papillomavirus genotyping microarrays, " Biomed. Opt. Expr., vol. 4, pp. 187-192, Feb. 1, 2013.
52. T. J. Baek, P. Y. Park, K. N. Han, H. T. Kwon, and G. H. Seong, "Development of a photodiode array biochip using a bipolar semiconductor and its application to detection of human papilloma virus, " Anal. Bioanal. Chem., vol. 390, pp. 1373-1378, Mar. 2008.
53. S. H. Chen et al., "Optical detection of human papillomavirus type 16 and type 18 by sequence sandwich hybridization with oligonucleotide-functionalized au nanoparticles, " IEEE Trans. Nanobiosci., vol. 8, pp. 120-131, Jun. 2009.
54. J. Y. Piao et al., "Direct visual detection of DNA based on the light scattering of silica nanoparticles on a human papillomavirus DNA chip, " Talanta, vol. 80, pp. 967-973, Dec. 15, 2009.
55. S. Palantavida, N. V. Guz, C. D. Woodworth, and I. Sokolov, "Ultrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancer, " Nanomed.-Nanotechnol. Biol. Med., vol. 9, pp. 1255-1262, Nov. 2013.
56. S. P. Wankhede et al., "Cell detachment model for an antibody-based microfluidic cancer screening system, " Biotechnol. Progr., vol. 22, pp. 1426-1433, Oct. 6, 2006.
57. L. Civit, A. Fragoso, S. Holters, M. Durst, and C. K. O'Sullivan, "Electrochemical genosensor array for the simultaneous detection of multiple high-risk human papillomavirus sequences in clinical samples, " Anal. Chimica Acta, vol. 715, pp. 93-98, Feb. 17, 2012.
58. D. S. Campos-Ferreira et al., "Electrochemical DNA biosensor for human papillomavirus 16 detection in real samples, " Analytica Chimica Acta, vol. 804, pp. 258-263, Dec. 4, 2013.
59. N. Nasirizadeh, H. R. Zare, M. H. Pournaghi-Azar, and M. S. Hejazi, "Introduction of hematoxylin as an electroactive label for DNA biosensors and its employment in detection of target DNA sequence and single-base mismatch in human papilloma virus corresponding to oligonucleotide, " Biosens. Bioelectron., vol. 26, pp. 2638-2644, Jan. 15, 2011.
60. S. Jampasa et al., "Electrochemical detection of human papillomavirus DNA type 16 using a pyrrolidinyl peptide nucleic acid probe immobilized on screen-printed carbon electrodes, " Biosens. Bioelectron., vol. 54, pp. 428-434, Apr. 15, 2014.
61. P. Liepold et al., "Electrically detected displacement assay (EDDA): A practical approach to nucleic acid testing in clinical or medical diagnosis, " Anal. Bioanal. Chem., vol. 391, pp. 1759-1772, Jul. 2008.
62. B. Piro et al., "Towards the detection of human papillomavirus infection by a reagentless electrochemical peptide biosensor, " Electrochimica Acta, vol. 56, pp. 10 688-10 693, 2011.
63. L. D. Tran, D. T. Nguyen, B. H. Nguyen, Q. P. Do, and H. Le Nguyen, "Development of interdigitated arrays coated with functional polyaniline/MWCNT for electrochemical biodetection: Application for human papilloma virus (vol 85, pg 1560, 2011), " Talanta, vol. 85, pp. 2715-2715, Oct. 15, 2011.
64. L. Xu et al., "Giant magnetoresistive biochip for DNA detection and HPV genotyping, " Biosens. Bioelectron., vol. 24, pp. 99-103, Sep. 15, 2008.
65. J. C. Rife et al., "Design and performance of GMR sensors for the detection of magnetic microbeads in biosensors, " Sens. Actuators A: Phys., vol. 107, pp. 209-218, Nov. 1, 2003.
66. H. Yang et al., "Giant magnetoimpedance-based microchannel system for quick and parallel genotyping of human papilloma virus type 16/18, " Appl. Phys. Lett., vol. 97, Jul. 26, 2010.
67. S. Peeters et al., "Specific magnetic isolation for direct detection of HPV16, " Eur. J. Clin. Microbiol. Infect. Dis., vol. 31, pp. 539-546, Apr. 2012.
68. D. Dell'Atti et al., "Development of combined DNA-based piezoelectric biosensors for the simultaneous detection and genotyping of high risk Human Papilloma Virus strains, " Clin. Chim. Acta, vol. 383, pp. 140-146, Aug. 2007.
69. Q. H. Chen et al., "Detection of hybridization of single-strand DNA PCR products in temperature change process by a novel metal-clamping piezoelectric sensor, " Biosens. Bioelectron., vol. 25, pp. 2161-2166, May 15, 2010.
70. P. Parsongdee, T. Limpaiboon, C. Leelayuwat, C. Promptmas, and P. Jearanaikoon, "Development of biosensor for high risk HPV detection in cervical cancer, " Nov. 26, 2014. [Online]. Available: http://gsbooks.gs.kku.ac.th/51/gradresearch10/file/MMO10.pdf
71. P. Prakrankamanant et al., "The development of DNA-based quartz crystal microbalance integrated with isothermal DNA amplification system for human papillomavirus type 58 detection, " Biosens. Bioelectron., vol. 40, pp. 252-257, Feb. 15, 2013.
72. S. Mobley et al., "Procedure for developing linear and Bayesian classification models based on immunosensor measurements, " Sens. Actuators B: Chem., vol. 190, pp. 165-170, 2014.
73. Y. X. Wang et al., "Rapid detection of human papilloma virus using a novel leaky surface acoustic wave peptide nucleic acid biosensor, " Biosens. Bioelectron., vol. 24, pp. 3455-3460, Aug. 15, 2009.
74. L. Q. Zhang et al., "A new system for the amplification of biological signals: RecA and complimentary single strand DNA probes on a leaky surface acoustic wave biosensor, " Biosens. Bioelectron., vol. 60, pp. 259-264, Oct. 15, 2014.
75. A. Molijn, B. Kleter, W. Quint, and L.-J. v. Doorn, "Molecular diagnosis of human papillomavirus (HPV) infections, " J. Clin. Virol., vol. 32, pp. 43-51, 2005.
76. P. Birner et al., "Signal-Amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions, " Mod. Pathol., vol. 14, pp. 702-709, 2001.
77. M. Schiffman et al., "Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA, " J. Clin. Microbiol., vol. 29, pp. 573-577, 1991.
78. M. Poljak, I. J. Marin, K. Seme, and A. Vince, "Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail, " J. Clin. Virol., vol. 25, pp. 89-97, 2002.
79. Cervista HPV HR, Nov. 19, 2010. [Online]. Available: http://www.cervistahpv.com/laboratory/cervistahpvhr/
80. D. A. Heideman et al., "Clinical validation of the cobas 4800 HPV test for cervical screening purposes, " J. Clin. Microbiol., vol. 49, pp. 3983-3985, Nov. 2011.
81. S. Hojvat, P100042 APTIMA HPV Assay, K. Godfredsen, Ed., vol. 8, pp. 98-107, 2008, KKU Research Journal Graduate Studies.
82. S. Ratnam et al., "Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer, " J. Clin. Microbiol., vol. 48, pp. 2779-2785, Aug. 2010.
83. G. Mehlhorn et al., "HPV L1 detection discriminates cervical precancer from transient HPV infection: A prospective international multicenter study, " Mod. Pathol., vol. 26, pp. 967-974, 2013.
84. H. Shafiee et al., "Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate, " Small, vol. 9, pp. 2553-2563, Aug. 12, 2013.
85. C. Lissandrello et al., "Nanomechanicalmotion of Escherichia coli adhered to a surface, " Appl. Phys. Lett., vol. 105, p. 113701, 2014.
86. S. Wang et al., "Efficient on-chip isolation of HIV subtypes, " Lab on a Chip, vol. 12, pp. 1508-1515, 2012.
87. S. Wang et al., "Portable microfluidic chip for detection of Escherichia coli in produce and blood, " Int. J. Nanomed., vol. 7, pp. 2591-2600, 2012.
88. H. Shafiee et al., "Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets, " Sci. Rep. 5, Mar. 6, 2015, (online), doi: 10.1038/srep08719.
89. S. Tasoglu, S. C. Park, J. J. Peters, D. F. Katz, and A. J. Szeri, "The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel, " J. Non-Newtonian Fluid Mechanics, vol. 166, pp. 1116-1122, 2011.
90. S. Tasoglu et al., "The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle, " Phys. Fluids, vol. 23, 2011, Art. ID. 093101.
91. S. Tasoglu, D. F. Katz, and A. J. Szeri, "Transient spreading and swelling behavior of a gel deploying an anti-HIV microbicide, " J. Non-Newtonian Fluid Mechanics, pp. 187-188, 36-42, 2012.
92. S. Tasoglu, L. C. Rohan, D. F. Katz, and A. J. Szeri, "Transient swelling, spreading and drug delivery by a dissolved anti-HIV microbicide-bearing film, " Phys. Fluids, vol. 25, no. 3, 2013, Art. ID. 031901.
93. F. Wang-Johanning and G. L. Johanning, "Viral detection, " Meth. Mol. Biol., vol. 292, pp. 3-14, 2005.
94. F. Wang-Johanning, D. W. Lu, Y. Wang, M. R. Johnson, and G. L. Johanning, "Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-Time polymerase chain reaction analysis, " Cancer, vol. 94, pp. 2199-2210, Apr. 15, 2002.
95. C. Kemp et al., "Direct processing of clinically relevant large volume samples for the detection of sexually transmitted infectious agents from urine on a microfluidic device, " Anal. Meth., vol. 4, pp. 2141-2144, 2012.
96. UNITAID, HIV/AIDS Diagnostic Technology Landscape Report, 2013. [Online]. Available: http://www.unitaid.eu/images/marketdynamics/publications/UNITAIDHIV-Diagnostic-Landscape-3rd-edition.pdf
97. H. Shafiee et al., "Emerging technologies for point-of-care management of HIV infection, " Ann. Rev. Med., vol. 16, 2015.
98. A. Rao et al., "Development and characterization of the cobas human papillomavirus test, " J. Clin. Microbiol., vol. 51, pp. 1478-1484, May 2013.
99. S. Wang, F. Xu, and U. Demirci, "Advances in developing HIV-1 viral load assays for resource-limited settings, " Biotechnol. Adv., vol. 28, pp. 770-781, Nov./Dec. 2010.
100. V. Mani et al., "Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care, " Adv. Drug Deliv. Rev., Jun. 2, 2014.
101. U. H. Yildiz et al., "Recent advances in micro/nanotechnologies for global control of hepatitis B infection, " Biotechnol. Adv., to be published.
102. S. Wang et al., "Micro-A-fluidics ELISA for rapid CD4 cell count at the point-of-care, " Sci. Rep., vol. 4, p. 3796, 2014.
103. S. Wang et al., "Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care, " Lab on a Chip, vol. 11, pp. 3411-3418, Oct. 21, 2011.